• Something wrong with this record ?

Protein-Ligand Interactions in the STING Binding Site Probed by Rationally Designed Single-Point Mutations: Experiment and Theory

Z. Vavřina, O. Gutten, M. Smola, M. Zavřel, Z. Aliakbar Tehrani, V. Charvát, M. Kožíšek, E. Boura, G. Birkuš, L. Rulíšek

. 2021 ; 60 (8) : 607-620. [pub] 20210215

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

STING protein (stimulator of interferon genes) plays an important role in the innate immune system. A number of potent compounds regulating its activity have been reported, mostly derivatives of cyclic dinucleotides (CDNs), natural STING agonists. Here, we aim to provide complementary information to large-scale "ligand-profiling" studies by probing the importance of STING-CDN protein-ligand interactions on the protein side. We examined in detail six typical CDNs each in complex with 13 rationally devised mutations in STING: S162A, S162T, Y167F, G230A, R232K, R232H, A233L, A233I, R238K, T263A, T263S, R293Q, and G230A/R293Q. The mutations switch on and off various types of protein-ligand interactions: π-π stacking, hydrogen bonding, ionic pairing, and nonpolar contacts. We correlated experimental data obtained by differential scanning fluorimetry, X-ray crystallography, and isothermal titration calorimetry with theoretical calculations. This enabled us to provide a mechanistic interpretation of the differences in the binding of representative CDNs to STING. We observed that the G230A mutation increased the thermal stability of the protein-ligand complex, indicating an increased level of ligand binding, whereas R238K and Y167F led to a complete loss of stabilization (ligand binding). The effects of the other mutations depended on the type of ligand (CDN) and varied, to some extent. A very good correlation (R2 = 0.6) between the experimental binding affinities and interaction energies computed by quantum chemical methods enabled us to explain the effect of the studied mutations in detail and evaluate specific interactions quantitatively. Our work may inspire development of high-affinity ligands against the common STING haplotypes by targeting the key (sometimes non-intuitive) protein-ligand interactions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019104
003      
CZ-PrNML
005      
20230519085131.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.biochem.0c00949 $2 doi
035    __
$a (PubMed)33586948
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vavřina, Zdeněk $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic $u Department of Biochemistry, Faculty of Science, Charles University, Prague 110 00, Czech Republic
245    10
$a Protein-Ligand Interactions in the STING Binding Site Probed by Rationally Designed Single-Point Mutations: Experiment and Theory / $c Z. Vavřina, O. Gutten, M. Smola, M. Zavřel, Z. Aliakbar Tehrani, V. Charvát, M. Kožíšek, E. Boura, G. Birkuš, L. Rulíšek
520    9_
$a STING protein (stimulator of interferon genes) plays an important role in the innate immune system. A number of potent compounds regulating its activity have been reported, mostly derivatives of cyclic dinucleotides (CDNs), natural STING agonists. Here, we aim to provide complementary information to large-scale "ligand-profiling" studies by probing the importance of STING-CDN protein-ligand interactions on the protein side. We examined in detail six typical CDNs each in complex with 13 rationally devised mutations in STING: S162A, S162T, Y167F, G230A, R232K, R232H, A233L, A233I, R238K, T263A, T263S, R293Q, and G230A/R293Q. The mutations switch on and off various types of protein-ligand interactions: π-π stacking, hydrogen bonding, ionic pairing, and nonpolar contacts. We correlated experimental data obtained by differential scanning fluorimetry, X-ray crystallography, and isothermal titration calorimetry with theoretical calculations. This enabled us to provide a mechanistic interpretation of the differences in the binding of representative CDNs to STING. We observed that the G230A mutation increased the thermal stability of the protein-ligand complex, indicating an increased level of ligand binding, whereas R238K and Y167F led to a complete loss of stabilization (ligand binding). The effects of the other mutations depended on the type of ligand (CDN) and varied, to some extent. A very good correlation (R2 = 0.6) between the experimental binding affinities and interaction energies computed by quantum chemical methods enabled us to explain the effect of the studied mutations in detail and evaluate specific interactions quantitatively. Our work may inspire development of high-affinity ligands against the common STING haplotypes by targeting the key (sometimes non-intuitive) protein-ligand interactions.
650    _2
$a vazebná místa $7 D001665
650    _2
$a krystalografie rentgenová $7 D018360
650    _2
$a lidé $7 D006801
650    _2
$a vodíková vazba $7 D006860
650    _2
$a membránové proteiny $x chemie $x genetika $x metabolismus $7 D008565
650    _2
$a molekulární struktura $7 D015394
650    _2
$a nukleotidy cyklické $x chemie $x metabolismus $7 D009712
650    12
$a bodová mutace $7 D017354
650    _2
$a konformace proteinů $7 D011487
650    _2
$a proteinové domény $7 D000072417
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gutten, Ondrej $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic
700    1_
$a Smola, Miroslav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic
700    1_
$a Zavřel, Martin $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic
700    1_
$a Aliakbar Tehrani, Zahra $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Průmyslová 595, Vestec 252 50, Czech Republic
700    1_
$a Charvát, Vilém $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic
700    1_
$a Kožíšek, Milan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic
700    1_
$a Boura, Evzen $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic
700    1_
$a Birkuš, Gabriel, $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic $d 1972- $7 xx0301324
700    1_
$a Rulíšek, Lubomír $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 2, Prague 16610, Czech Republic
773    0_
$w MED00009310 $t Biochemistry $x 1520-4995 $g Roč. 60, č. 8 (2021), s. 607-620
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33586948 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20230519085124 $b ABA008
999    __
$a ok $b bmc $g 1690024 $s 1139550
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 60 $c 8 $d 607-620 $e 20210215 $i 1520-4995 $m Biochemistry (Easton) $n Biochemistry $x MED00009310
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...